The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Aggressiveness of care and overall survival in young metastatic colorectal cancer patients.
 
Madeleine Fish
No Relationships to Disclose
 
Katie Kanter
No Relationships to Disclose
 
Gianluca Mauri
No Relationships to Disclose
 
Nora Horick
No Relationships to Disclose
 
Jill N Allen
No Relationships to Disclose
 
Lawrence Scott Blaszkowsky
No Relationships to Disclose
 
Jeffrey William Clark
Consulting or Advisory Role - Emas pharma
Research Funding - Pfizer (Inst)
 
David P. Ryan
Stock and Other Ownership Interests - Acworth Pharmaceuticals; MPM Capital
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - Gritstone Bio; MPM Capital; Oncorus
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; McGraw Hill Chapter Royalties
Other Relationship - TCR2 Therapeutics
 
Ryan David Nipp
No Relationships to Disclose
 
Bruce J. Giantonio
No Relationships to Disclose
 
Lipika Goyal
Consulting or Advisory Role - Debiopharm Group
Research Funding - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Debiopharm Group; Taiho Pharmaceutical
 
Janet E. Murphy
No Relationships to Disclose
 
Eric Roeland
Consulting or Advisory Role - AIM Specialty Health; BASF; Helsinn Healthcare (Inst); Immuneering; Napo Pharmaceuticals; Oragenics; Pronova (Inst)
 
Colin D. Weekes
Honoraria - Celgene; Lilly; Merrimack
Consulting or Advisory Role - Celgene; Merrimack
Research Funding - Abbvie; Bayer; Celgene; Genentech/Roche; Lilly; Millennium
 
Jennifer Yon-Li Wo
No Relationships to Disclose
 
Theodore S. Hong
Consulting or Advisory Role - Clinical Genomics; EMD Serono
Research Funding - AstraZeneca (Inst); clinical genomics (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
Andrew X. Zhu
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Lilly; Merck; Novartis; Roche/Genentech
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Emily E. Van Seventer
No Relationships to Disclose
 
Ryan Bruce Corcoran
Stock and Other Ownership Interests - Avidity Biosciences; nRichDx
Consulting or Advisory Role - Amgen; Array BioPharma; Astex Pharmaceuticals; Avidity Nanomedicines; Bristol-Myers Squibb; Chugai Pharma; FOGPharma; Genentech; Loxo; Merrimack; N-of-One; nRichDx; Roche; Roivant; Shire; Spectrum Pharmaceuticals; Symphogen; Taiho Pharmaceutical; Warp Drive Bio
Research Funding - AstraZeneca; Sanofi
 
Aparna Raj Parikh
Consulting or Advisory Role - Driver, Inc; Eisai; Foundation Medicine; PureTech
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); OncoMed (Inst); Plexxikon (Inst); Tolero Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Eisai